Raqia Therapeutics
Drew Dennison is on the Board of Directors at Raqia Therapeutics. Drew is also the Managing Director at Lightchain Capital, LLC.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Raqia Therapeutics
Raqia Therapeutics is an exciting startup company developing a transformative chimeric antigen receptor (CAR) technology for immunotherapy. At Raqia Therapeutics, they are motivated to bring life-changing therapy to patients with cancer.